WELCOME TO THE MPN EDUCATION FOUNDATION
September is National Blood Cancer Awareness Month
Myeloproliferative neoplasms (MPN) are relatively rare chronic hematologic malignancies that include the classic Myeloproliferative Neoplasm Disorders:
Philadelphia chromosome-negative Philadelphia chromosome-positive
Essential Thrombocythemia (ET) Chronic Myelogenous Leukemia (CML)
Polycythemia Vera (PV
There are atypical Myeloproliferative Neoplasm Disorders which include molecularly defined PDGFRA-rearranged eosinophilic/mast cell disorders; PDGFRB-rearranged eosinophilic disorders; systemic mastocytosis associated with c-kit mutation; 8p11 Myeloproliferative syndrome; and juvenile myelomonocytic leukemia with recurrent mutations of RAS. MPN also includes the clinicopathologically assigned variants: chronic neutrophilic leukemia; chronic eosinophilic leukemia; hypereosinophillic syndrome, chronic basophilic leukemia, chronic monomyelomonocytic leukemia, systemic mastocytosis; and unclassified myeloproliferative disorder. Chronic myeloid disorders also include myelodysplastic syndrome.
If you or a loved one have been diagnosed with one of these rare disorders,
YOU ARE NOT ALONE, HELP IS JUST A CLICK AWAY.
Scientific Advisory Board:
John Camoriano, MD, Mayo Clinic, Scottsdale, Arizona
Joachim Deeg, MD, Fred Hutchinson Cancer Research Center, Seattle, Washington
Claire Harrison, MD, Guy's and St. Thomas' Hospital, London, UK
Ruben Mesa, MD, Mayo Clinic, Scottsdale, Arizona
Ayalew Tefferi, MD, Mayo Clinic, Rochester, Minnesota
Srdan Verstovsek, MD, MD Anderson Cancer Center, Houston, Texas